Humira Pens

Humira reduces joint inflammation and damage from rheumatoid arthritis by blocking a chemical activator of inflammation called tumor necrosis factor. Humira is an injection. It is given by self-Injection under the skin once every two weeks. Patients can learn to give their own injections or receive them from a family member or caregiver who has had proper instruction. Preloaded syringes are available as self-Injectable
Equivalent Brands:
Humira Pens equivalent/ substitute for brands Adfrar 40Mg, Exemptia 40 Mg/0.8Ml, Adalimumab Injection Mabura 40